Code of Federal Regulations (Last Updated: November 8, 2024) |
Title 10 - Energy |
Chapter I - Nuclear Regulatory Commission |
Part 26 - Fitness for Duty Programs |
Subpart G - Laboratories Certified by the Department of Health and Human Services |
§ 26.163 - Cutoff levels for drugs and drug metabolites.
-
§ 26.163 Cutoff levels for drugs and drug metabolites.
(a) Initial drug testing.
(2) At the licensee's or other entity's discretion, as documented in the FFD program policies and procedures, the licensee or other entity may require the HHS-certified laboratory to conduct special analyses of dilute(1) HHS-certified laboratories shall apply the following cutoff levels for initial testing of specimens to determine whether they are negative or positive for the indicated drugs and drug metabolites, except if validity testing indicates that the specimen is dilute as specified in paragraph (a)(2) of this section or the licensee or other entity has established more stringent cutoff levels:
Table 1 to Paragraph (a)(1) - Urine, Initial Test Cutoff Levels for Drugs and Drug Metabolites
Drug Drugs or drug metabolites Cutoff level
[nanograms
(ng)/mL]Marijuana metabolites 50 Cocaine metabolites 300 Opiate metabolites 2000 150 Opioids: Codeine/Morphine1 2,000 Hydrocodone/Hydromorphone 300 Oxycodone/Oxymorphone 100 6-acetylmorphine (6-AM) 10 Phencyclidine (PCP) 25 Amphetamines 1000 :2 AMP/MAMP3 500 MDMA4/MDA5 500 Table 2 to Paragraph (a)(1) - Oral Fluid, Initial Test Cutoff Levels for Drugs and Drug Metabolites
Drugs or drug metabolites Cutoff level1
[nanograms
(ng)/mL]Marijuana (THC)23 4 Cocaine/Benzoylecgonine 15 Opioids: Codeine/Morphine 30 Hydrocodone/Hydromorphone 30 Oxycodone/Oxymorphone 30 6-acetylmorphine (6-AM) 43 Phencyclidine (PCP) 10 Amphetamines: AMP/MAMP4 50 MDMA/MDA5 50 (2) HHS-certified laboratories shall conduct special analyses of specimens as follows:
(i) If initial validity testing indicates that a specimen is dilute, the HHS-certified or if a specimen is collected under direct observation for any of the conditions specified in § 26.115(a)(1) through (3) or (a)(5), the laboratory shall compare the immunoassay responses of the dilute specimen to the cutoff calibrator in each of the drug classesclass tested;
(ii) If any immunoassay response is equal to or greater than 50 40 percent of the cutoff calibrator, the HHS-certified laboratory shall conduct confirmatory drug testing of the specimen down to the LOD LOQ for those drugs and/or drug metabolites; and
(iii) The laboratory shall report the numerical values obtained from this special analysis to the MRO.
(b) Confirmatory drug testing.
(1) A specimen that is identified as positive on an initial drug test must be subject to confirmatory testing for the class(es) of drugs for which the specimen initially tested positive. The HHS-certified laboratory shall apply the confirmatory cutoff levels specified in this paragraph, except if the licensee or other entity requires the special analysis of dilute specimens as permitted in paragraph (a)(2) of this section or the licensee or other entity has established more stringent cutoff levels.
Table 3 to Paragraph (b)(1) - Urine, Confirmatory Test Cutoff Levels for Drugs and Drug Metabolites
Drug Drugs or drug metabolites Cutoff level
(ng/mL)Marijuana metabolite1 15 Cocaine metabolite2 150 Opiates100 Opioids: Morphine 2000 Codeine 2000 2,000 Codeine 2,000 Hydrocodone 100 Hydromorphone 100 Oxycodone 100 Oxymorphone 100 6-acetylmorphine 3(6-AM) 10 Phencyclidine (PCP) 25 Amphetamines: Amphetamine 500 Methamphetamine4 500 250 Methamphetamine3 250 Methylenedioxymethamphetamine (MDMA) 250 Methylenedioxyamphetamine (MDA) 250 Table 4 to Paragraph (b)(1) - Oral Fluid, Confirmatory Test Cutoff Levels for Drugs and Drug Metabolites
Drugs or drug metabolites Cutoff level
[nanograms
(ng)/mL]Marijuana (THC) 2 Cocaine 8 Benzoylecgonine 8 Opioids: Codeine 15 Morphine 15 Hydrocodone 15 Hydromorphone 15 Oxycodone 15 Oxymorphone 15 6-acetylmorphine (6-AM) 2 Phencyclidine (PCP) 10 Amphetamines: Amphetamine 25 Methamphetamine 25 Methylenedioxymethamphetamine (MDMA) 25 Methylenedioxyamphetamine (MDA) 25 (2) Each confirmatory drug test must provide a quantitative result. When the concentration of a drug or metabolite exceeds the linear range of the standard curve, the laboratory may record the result as “exceeds the linear range of the test” or as “equal to or greater than <insert the value for the upper limit of the linear range>,” or may dilute an aliquot of the specimen to obtain an accurate quantitative result when the concentration is above the upper limit of the linear range.
[73 FR 17176, Mar. 31, 2008, as amended at 87 FR 71460, Nov. 22, 2022]